Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Reply # - July 16, 2016, 11:00 AM
Hi Connie,
Hi Connie,
I'm not sure why you only saw Biocept mentioned, because there are a number of companies which have entered the field. For example, eight of them are described in this article.
Some oncologists are embracing the procedure, but so far there are limitations to its usage. As Dr. West and his colleagues discuss in this podcast, while they can be used with good reliability to find resistance mutations, they shouldn't be relied upon to judge progression and dictate when treatment should be changed.
JimC
Forum moderator